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We developed and validated a new optical mapping system for quantiﬁcation of electrical activation and
repolarisation in murine atria. The system makes use of a novel 2nd generation complementary metal-
oxide-semiconductor (CMOS) camera with deliberate oversampling to allow both assessment of elec-
trical activation with high spatial and temporal resolution (128  2048 pixels) and reliable assessment of
atrial murine repolarisation using post-processing of signals. Optical recordings were taken from iso-
lated, superfused and electrically stimulated murine left atria. The system reliably describes activation
sequences, identiﬁes areas of functional block, and allows quantiﬁcation of conduction velocities and
vectors. Furthermore, the system records murine atrial action potentials with comparable duration to
both monophasic and transmembrane action potentials in murine atria.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Atrial ﬁbrillation is the most common sustained arrhythmia in
man and a common cause of stroke and cardiac deaths. Although
good progress has been made in the characterisation of factors that
cause AF (Camm et al., 2012a,b; Schotten et al., 2011; Wakili et al.,
2011), there is still an unmet need for better therapies to prevent
incident and recurrent AF (Camm et al., 2012a,b; Kirchhof et al.,
2013). Unravelling the mechanisms conveying the genetic basis of
atrial ﬁbrillation (Benjamin et al., 2009; Ellinor et al., 2012;
Gudbjartsson et al., 2007) is a promising and relatively new
avenue to novel preventive and therapeutic targets. Geneticallyr; AF, Atrial ﬁbrillation; APD,
omplementary metal-oxide-
m; LED, Light emitting diode;
ion potential; SEM, Standard
ntial; TIFF, Tagged image ﬁle
ciences, School of Clinical and
al Sciences, University of Bir-
þ44 (0)121 414 6938.
Ltd. This is an open access article ualtered murine models are popular tools for the study of molecular
disease mechanisms, including of atrial ﬁbrillation. Such models
allow the characterisation of the functional and molecular conse-
quences of deﬁned genetic alterations, thereby allowing us to
identify arrhythmia mechanisms attributable to such modiﬁca-
tions. This type of research extends the association studies in pa-
tients and populations which are limited by comorbidities, ethical
restraints and low sample availability (Riley et al., 2012). The small
size of murine hearts, particularly the atria, poses a challenge for
detailed electrophysiological assessment, and especially for high
density mapping of electrical activation and repolarisation.
Evolving knowledge of existence of regional heterogeneities calls
for the development of a technique with high spatial resolution, so
that the extent of heterogeneity can be identiﬁed (Di Diego et al.,
2013; Waldeyer et al., 2009). Additionally, the high frequency and
fast repolarisation properties of the murine atrium necessitate high
temporal resolution.
Optical mapping is an established technique for high spatial and
temporal resolution non-contact investigation of electrical excit-
ability of cardiac cells, tissues andwhole organs (Eﬁmov et al., 1994;
Lee et al., 2011; Rohr and Salzberg, 1994; Salama et al., 1987; Wu
et al., 2001). Optical mapping of cardiac tissue uses voltage-
sensitive dyes to visualise action potentials as changes innder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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(Salzberg et al., 1973). Numerous improvements have been made to
overcome technical difﬁculties associated with optical mapping of
cardiac tissue including removal of contraction artefacts in large
and small vertebrates by using uncouplers (Dou et al., 2007;
Fedorov et al., 2007; Jou et al., 2010; Wu et al., 1998) and sensi-
tive optical dyes (Eﬁmov and Fahy, 1997; Ehrenberg et al., 1987;
Rohr and Salzberg, 1994). As such, this technique has provided
important insights into the mechanisms of atrial arrhythmias in
murine models (Arora et al., 2003; Blana et al., 2010; Kirchhof et al.,
2011a,b). The complex electrophysiology of atrial ﬁbrillation
(Eckstein et al., 2013; Kirchhof et al., 2011a,b; Verheule and Tuyls,
2013), renders a higher spatial resolution of murine atrial activa-
tion and repolarisation mapping technology desirable. This allows
us to pinpoint further, the regional origins and patterns of AF
activation (Mandapati et al., 2000). Several foci of AF activation
have already been identiﬁed in genetically altered mouse models
(Benes et al., 2014; Faggioni et al., 2014). However, even with the
best available systems, the need for higher spatial and temporal
resolution combined with the small signal amplitude generated in
the thin atrial murine tissue still poses technical challenges.
To further improve temporal and spatial resolution in cardiac
optical imaging of murine atrial tissue, a second-generation com-
plementary metal-oxide-semiconductor (CMOS) camera is utilised
and novel algorithms developed to record and analyse atrial acti-
vation and repolarisation in the isolated, perfusedmurine atrium at
high spatial resolution. A spatial oversampling technique is
implemented to generate high-resolution activation maps at the
same time as high quality repolarisation information. The algo-
rithms used to generate isochronal maps and to perform APD
measurements are largely automated to limit user bias and to
facilitate high throughput analysis. Atrial optical action potentials
are compared with epicardial atrial monophasic action potentials
and atrial microelectrode transmembrane action potentials from
isolated hearts to validate the ﬁndings.
2. Methods
2.1. Heart isolation
All surgical procedures were performed according to the Ani-
mals (Scientiﬁc Procedures) Act, 1986 and were approved by the
Home Ofﬁce and the local authorities. Hearts were rapidly excised
by thoracotomy fromWTadult mice (3e7 months old), on a 129/Sv
or MF1 background, under terminal anaesthesia (200 mg/kg
pentobarbital sodium) administered by intraperitoneal injection.
2.2. High resolution mapping using novel methods of automated
data processing
Following isolation, hearts were mounted on a vertical Lan-
gendorff apparatus (Hugo Sachs, Germany) and the aorta retro-
gradely perfused with a standard bicarbonate buffered
KrebseHenseleit solution (see below), containing the voltage sen-
sitive dye Di-4-Anepps (50 mM; Biotium, California, USA) and the
excitation-contraction uncoupler blebbistatin (5 mM; Cayman
Chemical, Michigan, USA), a well-characterised substance used for
optical mapping (Fedorov et al., 2007; Kirchhof et al., 2011a,b). The
dye was stored in 25 ml aliquots of 5 mg/ml. For each experiment an
aliquot was mixed with 1 ml of Krebs solution and injected through
a bolus port in the Langendorff system over a period of 5 min. The
ﬂow rate of the Krebs solution was kept at 4 ml/min and at 36 C.
After 5 min of infusion, the atria were dissected and placed in a
superfusion chamber for image acquisition. A summary of the
system set-up used for image acquisition is shown in Fig. 1.Preparations were continuously superfused with Krebs and bleb-
bistatin to reduce contraction and paced incrementally
(300 mse80 ms paced cycle length) via platinum electrodes placed
in the tissue bath at twice the diastolic voltage threshold at 2 ms
pulse width. Stimuli were generated using an isolated constant
voltage stimulator (Digitimer, UK) driven by an analogue to digital
converter with spike2 software (Cambridge Electronic Design, UK).
The atria were ﬁeld illuminated by two twin LEDs at 530 nm (Cairn
Research, UK). These were required to provide sufﬁcient ﬁeld illu-
mination from all angles. A lens with a high numerical aperture
(Schneider Kreuznach Xenon 0.95/25, NA ¼ 0.52) was used to
collect as many photons as possible. Wide ﬁeld macroscopic images
of emitted ﬂuorescence (630 nm) were captured at a sampling
frequency of 1 or 2 kHz using a novel, high speed, high resolution
camera (128  2048 pixels, single pixel area: 6.5 mm by 6.5 mm,
ORCA ﬂash 4.0; Hamamatsu, Japan, Figs. 1 and 2). The camera reads
the data from the centre of the sensor. Temporal resolution can be
increased with reduced spatial resolution only in the vertical di-
rection, as a trade-off. This allows for the full window of the sensor
to be used in the horizontal direction. To reduce the read noise of
the camera, the 4  4 binning option was used (Fig. 2B and C).
Images were extracted and collated using WinFluor V3.4.9 (Dr
John Dempster, University of Strathclyde, UK) so that the ﬂuores-
cence intensity from a speciﬁc region of interest (4 4 pixels) could
be viewed as a single continuous waveform. This permitted the
identiﬁcation and monitoring of a greater number of optical action
potentials (OAPs) across the entire surface of the mouse atrium at
high spatial resolution. In addition, selected images could be
exported into uncompressed Tagged image ﬁle format (TIFF) for the
generation of whole atrial isochronal activation maps.
For the analysis of OAPs and generation of isochronal activation
maps, data were automatically processed using custom made al-
gorithms produced in MATLAB. For measurements of action po-
tential duration (APD), an initial sign change was necessary as the
emitted ﬂuorescence intensity is inversely proportional to trans-
membrane voltage (Loew,1996). Baseline subtractionwas achieved
by applying a ‘linear top hat ﬁlter’ to remove any ﬂuorescence drift.
At each cycle length, a maximum of 25 action potentials were
averaged to calculate the mean action potential waveform for a
selected region of interest (Fig. 1B). Previously we found that 25AP
signals were sufﬁcient to measure APD reliably. Fewer than 25 APs
could be used, but this was dependent on the signal quality from
each experiment. For example, a very good signal would require
less averaging, but to keep the algorithm consistent 25 signals were
routinely used. The baseline (100% repolarisation) was determined
as the mean ﬂuorescence signal recorded over 10 ms prior to
depolarisation. The point of activation was deﬁned as the peak rate
of change (dF/dtmax) and APD30, 50 and 70, were evaluated by
measuring the time from dF/dtmax to 30%, 50% and 70% repolar-
isation respectively (Fig. 1B). For each APD, the value usually falls
between sampling time points, 1 ms apart for 1000 fps, 0.5 ms for a
2000 fps. The repolarisation time was estimated by connecting
these two closest sampling time points above and below with
straight lines. A simple linear equation can be used to determine
the time for each APD.
Isochronal activation maps were produced after initially crop-
ping the exported image stack to isolate the region of interest; this
was the only step that required user input. Fluorescence intensity
from every pixel was automatically analysed in the z (time) axis.
The background was removed and signals were smoothed and then
ﬁltered using a SavitzkyeGolay ﬁlter, a moving average ﬁlter which
preserves signal morphology (Bachtel et al., 2011; Savitzky and
Golay, 1964). Signals were differentiated to detect the time of
activation, which was repeated until a 2D array (image) was
compiled with each element (pixel) corresponding to a speciﬁc
Fig. 1. Summary of the high resolution optical mapping systemwith automated analysis. A represents the schematic of the optical mapping system. The LA samples were excited by
four 530 nm LEDs, and ﬁltered through a high NA objective and a 630 nm long pass ﬁlter. The electrodes were used for programmed stimulation at 300e80 ms pacing cycle lengths.
Images were captured at a frame rate of 1000e2000 per second and recorded on a desktop computer for analysis using Winﬂuor software. The images above were recorded at
1000 frames per second. The electrodes can be seen on the upper left of the atrial image with the line of activation indicated by the black arrow. The action potentials indicate the
time at which the signals have reached that region. B This displays the outcome of an averaged signal taken from the left atrium stimulated at 100 ms CL (with standard errors.
Adjacent, is the same signal with its action potential durations labelled at APD30, 50 and 70 with the start of activation indicated by dF/dtmax shown. C The isochronal map is a
colour scale of the time taken to activate at each pixel, from the same atrium as above at 100 ms CL. The time increases in the direction opposite to where the electrodes are placed.
D Conduction vectors that indicate the direction of the wave are generated from the activation map.
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Fig. 1C). All other time values in relation to the origin could be
calculated (Fig. 1C) and then presented in the form of an isochronal
map.
For assessment of conduction velocities, the pixel size was
measured to be 71 mmand as each pixel represents a time value, the
velocity can be measured. The isochronal maps were generated as
mentioned above, with each time zone represented with a different
colour. From these maps the contours of the wave of propagation
were easily interpreted. To ensure accuracy, measurements were
always made perpendicular to the wavefront. Two points across
several ‘time zones’, usually a minimum of three, were selected.
From the distance and the difference in time between those points,
velocity was calculated in cm/second.
2.3. Monophasic action potentials
The new optical mapping system was validated by comparing
activation and repolarisation time with two established methods,
monophasic action potentials (MAP) (Blana et al., 2010; Kirchhof
et al., 2011a,b), and transmembrane action potentials obtained in
the same atrial preparations. Brieﬂy, for MAP acquisition, published
techniques (Blana et al., 2010; Kirchhof et al., 2011a,b; Knollmannet al., 2001) were employed and MAP recordings were obtained
in the intact, perfused heart immediately prior to dissecting the
atria for optical mapping. Whole hearts were cannulated and
mounted on a vertical Langendorff apparatus (Hugo Sachs, Ger-
many) and retrogradely perfused with standard bicarbonate buff-
ered KrebseHenseleit solution at 36e37 C, at constant perfusion
pressure (100 ± 5mmHg) and coronary ﬂow (4 ± 0.5 ml/min). A 2.0
French octapolar mouse electrophysiological catheter with elec-
trodes sized 0.5 mm and spaced at 0.5 mm (CIB'ERMOUSE, NuMED,
LLC., N.Y., USA) was inserted into the right atrium for pacing
(120 mse80 ms, 2 ms pulse width). Stable left atrial MAP re-
cordings were obtained using a miniaturised MAP catheter
mounted on spring-loaded electrode holder. Voltage signals were
ampliﬁed, digitised and viewed on a PC loaded with iox2 software
(EMKA, France). Measurements of action potential duration (APD)
and inter-atrial activation times were acquired using algorithms
generated in iox2.
2.4. Transmembrane action potentials
Transmembrane murine atrial action potentials (TAP) were
recorded as published (Lemoine et al., 2011) immediately before or
after the optical mapping procedure. TAPs were recorded from
Fig. 2. Examples of raw data from different acquisition techniques. A Raw image of the left atria from the ORCA Flash 4.0. Two images can be seen as an image splitter from two
different wavelengths focused on the single sensor. Resolution shown here is at 128  2048 pixels. B Raw traces from the left atria over a period of 1 s showing 10 action potentials.
There is less noise in the region of measurement using 4  4 pixels (left) compared to single pixels which show very little information, with the action potentials barely visible
(right). C Comparison of two action potential signals normalised to lie between 0 and 1 taken at 100 ms cycle length (CL) of the same atria and same region of interest but at
different acquisition speeds. These signals showed very minute variation in signal as we can see in the overlay.
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cate glass microelectrodes (tip resistance 15e30 MU), ﬁlled with
3 M KCl. Voltage signals were ampliﬁed (Axoclamp 2B; Molecular
Devices, USA), digitised and displayed using spike2 software
(Cambridge Electronic Design, UK). The sampling frequency was
20 kHz. Preparations were paced successively (300 mse80 ms)
with platinum electrodes at twice the diastolic voltage threshold,
with a minimum of 50 APs recorded at each cycle length using an
isolated constant voltage stimulator (Digitimer, UK) driven by an
analogue to digital converter with Spike2 software (Cambridge
Electronic Design, UK). Measurements of APD and intra-atrial
activation times were obtained using custom-made spike2
algorithms.2.5. Solutions
For all experiments a standard bicarbonate buffered
KrebseHenseleit solution was used containing in mM: NaCl 118;
NaHCO3 24.88; KH2PO4 1.18; Glucose 5.55; Na-Pyruvate 5; MgSO4
0.83; CaCl2 1.8; KCl 3.52, equilibrated with 95% O2 and 5% CO2 and
heated to 36e37 C. Under these conditions the pHwasmaintained
at 7.4. For experiments with 1 mM ﬂecainide, the drug was added to
the superfusate and circulated for 15 min to reach steady state
(Blana et al., 2010) before capturing images.
2.6. Data analysis
Values are expressed as mean ± standard error of mean unless
otherwise stated. Statistical analysis was performed using one way
Analysis of Variance (ANOVA) with Bonferroni or Dunnett's posthoc analysis where appropriate (GraphPad Prism 5.01). Signiﬁcance
was taken as p < 0.05.
3. Results
After development and optimisation of the setup, the quality
of OAP recordings was sufﬁcient for generating isochronal maps
for conduction measurements from an initial 5/10 to currently 8/
10 of the hearts used due to quality criteria, while basic action
potential duration measurements could be acquired from all
hearts. For a data set to meet the criteria for conduction mea-
surements, the isochronal maps must show a clear direction of
wavefront propagation. This allowed for the selection of two
points across several ‘time zones’ for calculation of conduction
velocity.3.1. Optical action potentials
As for TAPs and MAPs, the optically generated action potentials
were characterised by a fast depolarisation and a slower repolar-
isation. The baseline correction adjusted the signal allowing for
OAP measurements in all preparations with accuracy (Fig. 3A).
Combining several of the oversampled regions, up to four pixels
were occasionally required to achieve sufﬁcient signal-to-noise
ratios for precise determination of the repolarisation phase of the
action potential. OAPs measured using this novel oversampling
method exhibited similar morphology and duration characteristics
when compared with those recorded using more standard elec-
trophysiology techniques (Fig. 3B and C). At 300 ms CL OAPs at
APD50 were 10.9 ± 0.9 ms and APD70 14.7 ± 1.2 ms and showed no
Fig. 3. Comparison of action potentials obtained using the high resolution optical systemwith other standard electrophysiological techniques. Characteristic raw trace examples of
LA (left atrium). A optical action potentials (OAP) acquired at 1 kHz. B transmembrane (TAP); and C monophasic (MAP) action potentials recorded at cycle lengths of 300 ms and
100 ms. D and E Grouped data showing consistency of optical action potential durations at 50% and 70% repolarisation compared with TAPs and MAPs at 300 ms and 100 ms cycle
lengths respectively. Error bars indicate þ SEM. Data presented is from 8 regions of interest (ROI) from 8 LAs (OAPs), 10 cells from 5 LAs (TAPs) and 14 recordings from 14 LAs (MAPs).
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Fig. 3D). In another set of experiments, MAPs were recorded from
the intact, beating heart just prior to dissection of atrial tissue for
OAP measurement. We did not detect a signiﬁcant difference in
APD50 or APD70 between OAPs (9.6 ± 0.9 ms and 14.3 ± 1.4 ms
respectively) and TAPs and MAPs at a more physiological paced
cycle length of 100 ms (n ¼ 14, Fig. 3E). This degree of uniformity
therefore suggests that OAPs obtained using this technique can be
used to make accurate and reliable assessments of APDs in the
mouse atria.
3.2. Activation maps and conduction velocities
Example isochronal activation maps generated at different cycle
lengths for the entire LA are shown in Fig. 4A and demonstrate in
greater detail an obvious slowing of the activation spread at shorter
cycle lengths. Accordingly, atrial conduction times, measured from
the time point of stimulation to the fastest upstroke of the TAP
(Fig. 4B) or MAP (Fig. 4C) were prolonged at 100ms and 80ms cycle
lengths. Fig. 4D illustrates the recording positions of TAP and MAP
with respect to the stimulation site. Fig. 4E gives mean conduction
velocities (CV), measured with the new optical mapping setup, and
throughout the entire left atriumat different paced cycle lengths. CV
drops at higher paced cycle length, as expected (CV: 43.0 ± 1.3 cm/
se22.0 ± 4.7 cm/s from 300 ms to 80 ms CL respectively). Fig. 4F
illustrates the parallel increase in atrial activation times measured
by TAP (left atrial stimulation to mid-LA recording site) and byMAP
(right atrial septal stimulation to distant LA recording site). Due to
the higher intrinsic rate of the intact, beating heart (including the
right atrium and the sinus node),MAP recordingswere not available
at 300 ms paced cycle length.When adding the sodium channel blocker ﬂecainide to the
superfusion (1 mM), we observed an expected slowing in atrial
conduction spread (Fig. 5A and B). The isochronal maps clearly
demonstrate that ﬂecainide superfusion produces a well-deﬁned
region of functional conduction block in the mid-to inferior left
atrium, disturbing the normal pattern of electrical propagation,
severely prolonging activation time in certain areas and potentially
predisposing to re-entrant arrhythmia (see supplementary video
ﬁle; Fig. 5B).
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.pbiomolbio.2014.07.012.
Thus, in summary, our setup reliably reﬂects physiological
changes in atrial activation and visualises the propagation of elec-
trical activation waves across the entire murine left atrium, as well
as allowing for accurate calculation of APD and intra-atrial con-
duction velocity at any deﬁned region. In addition, this optical
mapping system can be used to more deﬁnitively trace disordered
electrical conduction in the mouse atrium, potentially induced by
pharmacological agents, genetic manipulation or features common
in certain models of pathology such as heart failure.
4. Discussion
4.1. Main ﬁndings
A novel system for optical mapping of electrical activation and
repolarisation in the murine atrium is described. The system
makes use of new imaging technology, namely a high-resolution
2nd generation CMOS camera, to achieve high temporal and
spatial resolution of electrical activation and repolarisation in the
murine atrium. It is demonstrated that recording is feasible using
Fig. 4. Activation wave propagation across the murine left atrium and conduction velocities at different pacing cycle lengths. A Examples of the activation spread across the same
left atrium at different cycle lengths as recorded by the new optical mapping system at 1 kHz. The high resolution isochronal maps indicate that at shorter cycle lengths the
activation time across the whole tissue is increased. A similar, but less detailed, pattern of delayed activation at shorter cycle lengths is shown using recordings of B TAPs and C
MAPs, as evidenced by the increase in time from the stimulus artefact to the point of activation (Vmax). D A schematic of the atria showing the stimulus and recording sites for the
three techniques. When using optical mapping the whole left atrium is imaged and stimulated towards the septum. For TAP recordings the stimulation site is the same but the
recording site is approximately in the centre of the tissue. Epicardial left atrial MAP signals were recorded from the intact whole heart and stimulated at the endocardial surface of
the right atrium with the octapolar catheter. EMean conduction velocities at different cycle lengths, n ¼ 3 LA. Error bars indicate ± SEM, * denotes P < 0.05 compared with velocity
at 300 ms CL; one way repeated measures ANOVAwith Dunnett's post hoc analysis. F TAP and MAP activation times at decreasing cycle lengths. Data presented is from 10 cells from
5 LAs (TAPs) and 31 recordings from 31 LAs (MAPs). Error bars indicate ± SEM, * denotes P < 0.05 compared with activation time at 300 ms CL; one way ANOVAwith Dunnett's post
hoc analysis.
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action potential waveforms and action potential durations when
compared to monophasic and transmembrane atrial action po-
tentials. Furthermore, it is shown that the system is capable of
detecting changes in conduction velocity and functional con-
duction block. In our hands, the oversampling of recordings
allows us to maximise the information collected in each experi-
ment, as a higher spatial resolution is conducive to the detection
of small activation changes, while larger sampling areas are
acceptable for the assessment of atrial repolarisation, where a
higher signal to noise ratio may be needed to accurately deter-
mine action potential duration. In addition to this, the algorithms
used are useful in reducing the time needed for a user to analyse
APD measurements and produce activation maps. For example, to
correct for baseline shifts, it is common to ﬁt a linear or poly-
nomial equation to the signal (Laughner et al., 2012). In our
experiments, these baseline shifts were extremely variable. We
therefore had to use a different approach to existing correctionmethods. Here we use a common top hat ﬁlter normally applied
to 2D quality images but on a 1D signal on our action potentials.
Another example is the detection of t ¼ 0 on the isochronal maps.
It is a useful tool for speeding up analysis and again, for limiting
user bias.
Assessment of murine atrial electrophysiology is an essential
tool to understand the functional consequences of deﬁned genetic
modiﬁcations, including complex gene expression changes e.g.
secondary to altered function of transcription factors (Kirchhof
et al., 2011a,b; Riley et al., 2012; Wang et al., 2010), or the effects
of inhibitory or regulatory RNA molecules. Environmental factors
like the effect of training, interventions and chronic or acute drug
treatment (Fabritz et al., 2010, 2011) can be assessed with the
increased number of pixels in this system in the future, including
larger and irregular specimens. The increased spatial resolution in
this systemwill also allow us to identify heterogeneities within the
tissue. Imaging of murine embryos should also be possible with this
system (Benes et al., 2014).
Fig. 5. Functional conduction block (induced by ﬂecainide) in the murine left atrium. A
Characteristic activation spread across the left atrium under control conditions, taking
approximately 15 ms to traverse the whole tissue when paced at 100 ms CL. B Dis-
rupted activation wave propagation across the same left atrium following 15 min of
1 mM ﬂecainide infusion. A clearly deﬁned region of functional conduction block de-
velops and is outlined in black. An alternative route of conduction (black arrow) is
required and this causes a substantial increase in activation time (25 ms). Both images
acquired at 1 kHz sampling.
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generation oversampling high-resolution CMOS camera with high
light sensitivity, we were able to record electrical activation and
repolarisation with high accuracy and reliability, yielding infor-
mation that reﬂects murine atrial biology (Figs. 2e4). The ORCA
camera has very recently been used and shown to capture action
potentials in spontaneously spiking HEK cells (Park et al., 2013).
Signals from HEK cells occur at approximately 3 APs per second.
The pacing rate applied in our experiments in live intact organ
tissue was much higher and represented a higher challenge to the
camera resolution. The validation data suggest that the system can
reliably record atrial repolarisation, making it attractive for the
study of arrhythmia mechanisms in genetically altered murine
models that mimic inherited arrhythmogenic diseases and/or
replicate common gene expression changes associated with com-
mon cardiac diseases.4.2. Technical considerations
Optical mapping of mouse hearts has been used to characterise
arrhythmia mechanisms since the beginning of this century.
Initially, systems were developed to measure ventricular activation
and repolarisation (Baker et al., 2000; Brunner and Kodirov, 2003),
and more recently expanded to atrial preparations (Glukhov et al.,
2010; Kirchhof et al., 2011a,b; Verheule et al., 2004). One of the
most commonly used systems is the custom-made SCIMEDIA sys-
tem that provides a 100  100 pixel ﬁeld at high temporal resolu-
tion (Bezzina et al., 2013; Kirchhof et al., 2011a,b). Especially at high
sampling rates, the relatively low signal strength generated by the
thin murine atrial tissue has been a challenge. The system devel-
oped and validated here uses emerging technology, i.e. a 2nd
generation CMOS camera capable of detecting low amplitude light
signals at superior spatial resolution (128  2048 pixels) and good
temporal resolution (1e2 kHz). A higher temporal resolution is
needed when capturing quick cellular changes, e.g. action potential
depolarisation. A higher spatial resolution is desirable when trying
to precisely locate phenomena changing at a lower rate. With this
resolution span, each individual pixel provides a signal with a
relatively low signal to noise ratio, due to the limited number of
light emitting events of the recorded tissue. The spatialoversampling of the signals during data acquisition allows the post-
processing of signals to optimise the information per pixel. Spe-
ciﬁcally, a high spatial resolution is used to assess atrial activation
with optimal accuracy and an acceptable signal to noise ratio. The
employed algorithm for correction of baseline ﬂuctuation was
robust to all types of e sometimes random e changes in baseline
ﬂuorescence, thus increasing the reliability of the measurements
and the yield of analysable experiments. Reliable assessment of
repolarisation, in contrast, was possible using combination of in-
dividual signals in the analysis phase, thereby sacriﬁcing some of
the spatial resolution, and by signal averaging during steady state
pacing. Thus, the proposed new, versatile system allows the
adjustment of image parameters after the end of the experiment to
suit speciﬁc analysis needs, therefore increasing the information
yield from each experiment.
This system was capable of recording valid action potential
waveforms over a wide range of paced cycle lengths, and with
simultaneous recording of action potential durations from all re-
gions of the left atrium. Using the post-processing methods
described above, this systemwill provide detailed insights into the
regional differences in atrial action potential duration, and their
change in genetically modiﬁed models.
The preparation used here was stable over experimental pro-
tocols of 1e1.5 h duration, demonstrating that superfusion of the
murine atrium is adequate to maintain the integrity of the super-
fused atrium during acute interventions such as antiarrhythmic
drugs (Fig. 5) at bradycardic and physiological cycle lengths.
Automated analysis of APD and activation patterns is another
important feature of the present system. Semi-automated pro-
cedures, involving the investigator in the initial selection of suitable
recording periods and in the deﬁnition of suitable regions of in-
terest for assessment of repolarisation, combined with automated
post-processing of such signals, allows valid, investigator-
controlled yet rapid and high-throughput recordings of electrical
activation and repolarisation in the intact murine atrium.
4.3. Limitations and further developments
The new optical mapping system can be used to characterise the
electrophysiological behaviour of murine atrial tissue in sufﬁcient
detail to describe arrhythmogenic changes in electrical activation
and repolarisation in murine atria. The isolated superfused, dye-
loaded atrium is sufﬁciently stable to allow the assessment of
acute effects of pharmacological interventions such as antiar-
rhythmic drugs or miRNAs. Cross-over designs, e.g. giving a sub-
stance initially and observing the reverse effect during wash out
(Blana et al., 2010), can be used in the future to demonstrate sta-
bility of the preparation even better. As such, it will be useful to
describe arrhythmia mechanisms in genetically modiﬁed mice
(Riley et al., 2012), especially when paired experiments in geneti-
cally modiﬁed and wild type mice are done in direct sequence,
maintaining blinding during the analysis. The system was stable in
assessing a cycle length of 100 ms for several minutes, but for even
higher heart rates, a perfusion systemwould be beneﬁcial to adjust
for increased metabolic demand. Assessment of APD needed an
uncoupler, but assessment of conduction velocity might be possible
without an uncoupler in the near future by ﬁltering techniques
following the sharp upstroke of the action potential. Working
without an uncoupler physiologically is an advantage especially if
working with models of mechano-electrical feedback (Fabritz et al.,
2012, 2011; Kohl et al., 1999).
This system seems capable of detecting regional differences in
activation (Figs. 4 and 5) and repolarisation (illustrated by the
capability to measure action potential duration at one single site in
all experiments). The semi-automated analysis combined with the
T.Y. Yu et al. / Progress in Biophysics and Molecular Biology 115 (2014) 340e348 347high and adjustable spatial resolution will allow the generation of
regional information quickly and reliably. The software can be
further automatised, and source data made compatible with
existing analysis platforms for optical activation maps and repo-
larisation shapes to ensure transferability of the results, ideally in
an open access development process. Future developments may
make use of calcium-sensitive dyes to assess calcium release pat-
terns in the isolated, superfused atrium.
Use of a 4  4 pixel average for a regional measurement can, in
theory, affect the upstroke delay as this area is a combination of
several cardiomyocytes. Despite this, it is common practice to use a
slightly higher regional area to gain signal quality. The signal to
noise level does not allow automated analysis of action potential
peaks at present with the information from only one pixel. The
intensity of emitted light seems the major limitation inhibiting yet
ﬁner spatial and temporal resolution in the proposed setup. New
optical dyes with higher optical yields may help to further improve
resolution and reliability of the system (Lee et al., 2012a,b; Lee et al.,
2012a,b). Local stimulation at a deﬁned point within the atrial tis-
sue will allow us to discern longitudinal and transverse conduction
properties, and enable programmed stimulation protocols. Fixation
of the tissue at the end of the experiment, which was not done in
the present study, will allow us to relate regional electrophysio-
logical changes (e.g. conduction block, or differences in action po-
tential duration) to histological changes.
4.4. Conclusions
Using the techniques described above, murine atria but also
ventricular neonatal or embryonal whole hearts may be investi-
gated in the future, driving new insight into inborn errors leading
to cardiomyopathy, heart failure and arrhythmias.
This novel technique for optical mapping and analysis of optical
action potentials was developed as a tool for experimentation with
murine cardiac atrial electrophysiology and will help to drive in-
sights into how genetic changes and environmental factors inﬂu-
ence atrial activation and repolarisation properties, thereby helping
to elucidate mechanisms of atrial arrhythmias.
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